Okamura K, Nakashima T, Ueda K, Inoue K, Omae T, Fujishima M
Second Department of Internal Medicine, Faculty of Medicine, Kyushu University, Fukuoka City, Japan.
Int J Epidemiol. 1987 Dec;16(4):545-9. doi: 10.1093/ije/16.4.545.
Serum triiodothyronine (T3), thyroxine (T4), thyroid stimulating hormone (TSH) and thyroid autoantibodies (TAA) to either microsome or thyroglobulin were measured in 1251 samples from the general population, 546 males and 705 females, aged 40 or over in Hisayama, a Japanese rural town. TAA was positive in 7.7% of men and 15.0% of women, and the male/female ratio was 1:2. This ratio was markedly different from those in hospital patients with thyroid disorders where ratios such as 1:8 for chronic thyroiditis and 1:4 for Graves' disease were found. Among the study subjects, definite hyperthyroidism was found in 0.2%, borderline hyperthyroidism in 0.7%, overt hypothyroidism in 0.3%, latent hypothyroidism in 4.2%, and non-thyroid illness in 2.4%. Overt thyroid dysfunction was more evident in women, while latent thyroid dysfunction or non-thyroidal illness was equally prevalent in men and women. These results indicate that the incidence of immunologically or functionally latent thyroid disorders is rather higher than expected, in both women and men. Some unknown factor(s) might act as a trigger to manifest thyroid dysfunction, mainly in females.
在日本一个乡村小镇久山町,对1251名年龄在40岁及以上的普通人群样本(546名男性和705名女性)进行了血清三碘甲状腺原氨酸(T3)、甲状腺素(T4)、促甲状腺激素(TSH)以及针对微粒体或甲状腺球蛋白的甲状腺自身抗体(TAA)检测。TAA在7.7%的男性和15.0%的女性中呈阳性,男女比例为1:2。该比例与甲状腺疾病住院患者中的比例显著不同,在住院患者中,慢性甲状腺炎的比例为1:8,格雷夫斯病的比例为1:4。在研究对象中,确诊甲亢的占0.2%,临界甲亢的占0.7%,显性甲减的占0.3%,潜在甲减的占4.2%,非甲状腺疾病的占2.4%。显性甲状腺功能障碍在女性中更为明显,而潜在甲状腺功能障碍或非甲状腺疾病在男性和女性中同样普遍。这些结果表明,免疫或功能上潜在的甲状腺疾病在男性和女性中的发病率均高于预期。一些未知因素可能是导致甲状腺功能障碍显现的触发因素,主要在女性中。